In order to give better insight to the role of ZNF217 oncogene in larynx tumorigenesis, we aimed to analyse the frequency of ZNF217 copy number changes and to evaluate their relation to gender, tumor stage, tumor grade and metastatic potential. We combined fluorescent in situ hybridization (FISH) with ZNF217 specific probe, with a preexisting highthroughput tissue microarray (TMA), consisting of 863 larynx carcinomas. Gain of ZNF217 was detected in 22.66% of the cases with a significantly higher frequency (p<0.05) in primary tumors -stage IV compared to samples -stage I-III. ZNF217 gain was found predominantly in the group of primary tumors with metastases. None of the samples showed amplification. The technological advantage of FISH on TMA allows us to recognize gain of ZNF217 as an important abnormality, involved in larynx tumorigenesis.
Introduction
Laryngeal cancer is the most common cancer of the upper aerodigestive tract. The majority of patients with larynx carcinoma are diagnosed already in advanced tumor stage (T3-T4) which is a parameter for a worse prognosis.
An important aspect of tumorigenesis is amplification of DNA that allows cancer cells to up-regulate the expression of critical oncogenes. Several comparative genomic hybridization studies provide evidence for overrepresentation of chromosome 20q in different tumor types, including larynx cancer (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) .
ZNF217 oncogene (20q13.2) encodes a putative krüppel-like transcription factor and it has been proposed as target for amplification in breast (1), colon (14) and less frequently in ovarian cancer (15) .The only report for ZNF217 copy number changes in head and neck cancer was done by Freier et al (16) . They observed 3.6% of ZNF217 amplification by fluorescent in situ hybridization (FISH) on a tissue microarray (TMA) presented by head and neck cancers with different localization. The authors did not analyse the role of the increased copy number changes of ZNF217 for larynx tumorigenesis but rather for the development of head and neck tumors in general.
Since our TMA consists of 863 tumors only with larynx localization, we aimed to analyse the frequency of ZNF217 copy number changes and to evaluate their relation to gender, tumor stage, tumor grade and metastatic potential by fluorescent in situ hybridization (FISH) technique.
Materials and Methods
Larynx cancer tissue microarray A total of 863 formalin-fixed, paraffin-embedded samples from larynx cancer were collected. The histological slides from all collected paraffin blocks consisting of larynx tumors were reviewed prior to construction to define representative tumor regions. From these regions, tissue cylinders were obtained and arrayed into a recipient block using the tissue chip microar-rayer (Beecher Instruments, USA). The recipient block was cut into sections and used in the FISH procedure. H&E-stained sections were made from every TMA block and checked by a pathologist to confirm the high tumor cellularity. An overview of the clinicopathological data is given in Table 1 . Tumor stage and grade were defined according TNM system (17) . FISH procedure Pretreatment of slides was done with Paraffin Pretreatment Kit (Vysis, USA). FISH was performed applying a Spectrum Orangelabeled specific probe for ZNF217 gene that corresponds to 20q13.2 chromosomal region (Vysis, USA, Order Number 32-190016). Denaturation of the probe mixture and slides was at 75 ºC for 10 min. and 73 ºC for 5 min, respectively. Their hybridization was performed overnight at 37 ºC in a moist chamber. The post-hybridization washes were done following the 'LSA' procedure (Vysis, USA).
Classification of ZNF217 copy number changes
As recommended by Freier et al. (16) , the presence of more than two and less than eight gene signals in 10% of tumor cells were defined as gain. The presence of more than eight gene signals (dispersed or clustered) in 10% of tumor cells was defined as amplification. Normal samples were those which did not meet the criteria for gain or amplification.
Statistics
Fisher's exact test was used to study the relation between ZNF217 copy number changes and different subsets of tumor. Standard Chi -Square and p-value test were used to compare the possible relation of gene aberrations and tumor grade. Statistically significant results correspond to p≤0.05.
Results and Discussion
A subset of 863 larynx tumors was analyzed by FISH for ZNF217 gene. The results are presented in Table 2 . The FISH ZNF217 gain was found predominantly in the group of primary tumors which developed metastases -T1-4N1-3M0-1, compared to the primary tumors without metastases -T1-4N0M0 (30.23% vs. 20.59%, p=0.077). We did not observe an association between ZNF217 aberrations and gender, T1-2 vs. T3-4 tumor groups and tumor grade (p=0.388, p=0.179, p=0.42, respectively). None of the analysed samples showed gene amplification. The comparative genomic hybridization data reveals that overrepresentation of a gene or genes important for larynx pathogenesis resides on 20q chromosome arm (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . Tissue microarray technology is a very suitable approach for detecting gene copy number changes in these overrepresented chromosomal regions because of the large number of tumor materials, included in the chip (18).
In the present study we detected ZNF217 copy number changes in 22.66% of the analysed cases, due only to gain, by FISH on a large tissue microchip. This observation suggests that ZNF217 is involved predominantly in low-level amplification of the gene or it can be a consequence of additional copies of the whole chromosome 20. Alternatively, the increased gene copy number can result from structural chromosomal aberrations.
The study revealed significantly higher frequency of ZNF217 gain in advanced primary tumors -stage IV, compared to samples in stage I-III and a tendency for accumulation of the aberration in primary tumors which developed metastases. This result shows that gain of ZNF217 plays an important role for the larynx tumor development and it has an impact on the metastatic potential. In addition, Ashman et al. (19) found that 20q gain is significantly associated with reduced free survival in patients with head and neck cancer which seems in line with our results.
In conclusion, we showed that FISH on tissue microarray is a valuable technology to detect gene copy number changes in hundreds of tissues, simultaneously. The method allowed us to evaluate the involvement of ZNF217 in larynx pathogenesis. The observed relation of increased ZNF217 copy number changes with advanced tumor stage and metastatic potential demonstrate that this gene is involved in larynx progression.
